US Stock MarketDetailed Quotes
NVNO enVVeno Medical
- 3.350
- -0.020-0.59%
Close Nov 1 16:00 ET
- 3.300
- -0.050-1.49%
Post 20:02 ET
58.75MMarket Cap-2596P/E (TTM)
3.430High3.285Low75.76KVolume3.410Open3.370Pre Close253.47KTurnover0.43%Turnover RatioLossP/E (Static)17.54MShares6.97052wk High1.24P/B58.57MFloat Cap3.01252wk Low--Dividend TTM17.48MShs Float141.000Historical High--Div YieldTTM4.30%Amplitude2.510Historical Low3.345Avg Price1Lot Size
About enVVeno Medical Company
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include VenoValve and enVVe. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
Company Profile
SymbolNVNO
Company NameenVVeno Medical
Listing DateMay 31, 2018
Founded1999
CEOMr. Robert A. Berman
MarketNASDAQ
Employees31
Fiscal Year Ends12-31
Address70 Doppler
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92618
Phone1-949-261-2900
Websitehttp://www.envveno.com
Company Executives
- Name
- Position
- Salary
- Robert A. Berman
- Director and Chief Executive Officer
- 466.48K
- Dr. Marc H. Glickman, M.D.
- Senior Vice President and Chief Medical Officer
- 404.97K
- Craig Glynn
- Principal Accounting Officer, Chief Financial Officer and Treasurer
- 228.82K
- Dr. Francis Duhay
- Independent Director
- 70.00K
- Dr. Sanjay Shrivastava
- Independent Director
- 75.00K
- Matthew M. Jenusaitis
- Independent Director
- 75.00K
- Robert C. Gray
- Independent Director
- 77.50K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data